IgA-mediated antibody-dependent cellular cytotoxicity (ADCC) by neutrophils outperforms IgG-mediated ADCC using this cell subset, and when combined with CD47 blockade, the anti-tumor capacity can be greatly increased using IgA antibodies (13, 14). This evidence concerns the gene CD47 and neoplasm.